Jun 8, 2026 07:31AM
Jun 8, 2026 07:30AM
May 26, 2026 07:30AM
May 8, 2026 07:30AM
Apr 28, 2026 07:30AM
Apr 28, 2026 07:30AM
Apr 28, 2026 07:30AM Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
Mar 31, 2026 07:32AM
Mar 31, 2026 07:30AM
Feb 12, 2026 07:31AM
Feb 12, 2026 07:30AM
Nov 7, 2025 07:30AM
Aug 14, 2025 07:30AM
Jul 8, 2025 07:30AM Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
May 9, 2025 07:30AM
Mar 21, 2025 07:31AM
Mar 21, 2025 07:30AM
Aug 16, 2024 09:00AM
Aug 9, 2024 07:30AM
Jun 7, 2024 09:00AM
May 10, 2024 07:30AM Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
Mar 15, 2024 07:30AM
Nov 13, 2023 07:30AM
Aug 21, 2023 07:30AM
May 15, 2023 07:30AM
May 1, 2023 07:31AM
May 1, 2023 07:30AM
Mar 31, 2023 07:30AM Soligenix Announces Recent Accomplishments And Year-End 2022 Financial Results
Nov 10, 2022 07:30AM
Oct 21, 2022 09:30AM
Aug 12, 2022 07:30AM
Jul 25, 2022 07:31AM
Jul 25, 2022 07:30AM
Jun 3, 2022 08:00AM
May 13, 2022 07:30AM Soligenix Announces Recent Accomplishments And First Quarter 2022 Financial Results
Mar 29, 2022 07:30AM
Jan 10, 2022 07:30AM
Nov 12, 2021 07:30AM
Aug 13, 2021 07:30AM
Aug 11, 2021 10:03AM
Dec 22, 2020 09:00AM
Jan 14, 2020 07:06AM Soligenix, Inc. (SNGX) provides corporate update and guidance
Jan 14, 2020 07:00AM
Aug 14, 2017 10:08AM
Oct 7, 2016 06:00AM
Mar 24, 2016 07:00AM
Nov 12, 2015 07:00AM
Mar 24, 2015 07:00AM

1,160,146 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All